title: Comment on: 'Developing and paying for medicines for orphan indications in oncology: utilitarian regulation vs equitable care?'.
authors: S S
authors: SS
authors: Bielack
mesh_terms: D000970:Antineoplastic Agents / Q000191:economics*; D016527:Drug Costs; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy*; D009965:Orphan Drug Production / Q000191:economics*; D012935:Social Justice
chemical_list: D000970:Antineoplastic Agents